Purchases and Sales Made in Q4 2024 in Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX) during Q4 2024. The information is specifically focused on institutions that hold shares of BioLineRx Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Highbridge Capital Management LLC
New York, NY |
BUY
|
- |
1.01MNew |
$202K - $606K
|
1.01M
$3.43M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
69.2K+ 383.67% |
$13.8K - $41.5K
|
87.2K
$297K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
35.3KNew |
$7.06K - $21.2K
|
35.3K
$120K
|
|
|
Jan 08, 2025
Q4 2024
|
Watts Gwilliam & Co., LLC
Gilbert, AZ |
BUY
|
- |
34KNew |
$6.8K - $20.4K
|
34K
$116K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
31.3KNew |
$6.27K - $18.8K
|
31.3K
$107K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
20.2KNew |
$4.04K - $12.1K
|
20.2K
$68.7K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
15.3KNew |
$3.06K - $9.19K
|
15.3K
$52.1K
|
|
|
Jan 21, 2025
Q4 2024
|
Gradient Investments LLC
|
BUY
|
- |
11.4K+ 38.0% |
$2.28K - $6.84K
|
41.4K
$141K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
10.4K+ 31.74% |
$2.07K - $6.21K
|
43K
$146K
|
|
|
Jan 29, 2025
Q4 2024
|
Hibernia Wealth Partners, LLC
Baton Rouge, LA |
BUY
|
- |
10KNew |
$2K - $6K
|
10K
$34K
|
|
|
Jan 06, 2025
Q4 2024
|
Neville Rodie & Shaw Inc
|
BUY
|
- |
10KNew |
$2K - $6K
|
10K
$34K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
8.21K+ 834.55% |
$1.64K - $4.93K
|
9.2K
$31.3K
|
|
|
Feb 19, 2025
Q4 2024
|
Orin Green Financial, LLC
|
BUY
|
- |
8K+ 18.6% |
$1.6K - $4.8K
|
51K
$173K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
3.1KNew |
$621 - $1.86K
|
3.1K
$10.6K
|
|
|
Jan 21, 2025
Q4 2024
|
Geneos Wealth Management Inc.
|
BUY
|
- |
300+ 6.67% |
$60 - $180
|
4.8K
$16.3K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-1.1K- 8.44% |
$220 - $660
|
11.9K
$40.6K
|
|
|
Feb 13, 2025
Q4 2024
|
Rathbones Group PLC
Liverpool, X0 |
SELL
|
- |
-8.15K- 20.48% |
$1.63K - $4.89K
|
31.7K
$108K
|
|
|
Jan 07, 2025
Q4 2024
|
Weaver Consulting Group
|
SELL
|
- |
-18.7K- 63.02% |
$3.75K - $11.2K
|
11K
$37.4K
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-29.5K- 84.2% |
$5.9K - $17.7K
|
5.54K
$18.8K
|
|
|
Jan 29, 2025
Q4 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-31.1K- 15.73% |
$6.21K - $18.6K
|
166K
$566K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-118K- 59.96% |
$23.7K - $71.1K
|
79.1K
$269K
|